These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Lymph node but not intradermal injection site macrophages are critical for germinal center formation and antibody responses to rabies vaccination. Lytle AG; Shen S; McGettigan JP J Virol; 2015 Mar; 89(5):2842-8. PubMed ID: 25540370 [TBL] [Abstract][Full Text] [Related]
3. ICAM-1-based rabies virus vaccine shows increased infection and activation of primary murine B cells in vitro and enhanced antibody titers in-vivo. Norton JE; Lytle AG; Shen S; Tzvetkov EP; Dorfmeier CL; McGettigan JP PLoS One; 2014; 9(1):e87098. PubMed ID: 24489846 [TBL] [Abstract][Full Text] [Related]
4. Chimeric rabies virus-like particles containing membrane-anchored GM-CSF enhances the immune response against rabies virus. Kang H; Qi Y; Wang H; Zheng X; Gao Y; Li N; Yang S; Xia X Viruses; 2015 Mar; 7(3):1134-52. PubMed ID: 25768031 [TBL] [Abstract][Full Text] [Related]
5. Breakthrough of SIV strain smE660 challenge in SIV strain mac239-vaccinated rhesus macaques despite potent autologous neutralizing antibody responses. Burton SL; Kilgore KM; Smith SA; Reddy S; Hunter E; Robinson HL; Silvestri G; Amara RR; Derdeyn CA Proc Natl Acad Sci U S A; 2015 Aug; 112(34):10780-5. PubMed ID: 26261312 [TBL] [Abstract][Full Text] [Related]
6. Incorporating B cell activating factor (BAFF) into the membrane of rabies virus (RABV) particles improves the speed and magnitude of vaccine-induced antibody responses. Plummer JR; McGettigan JP PLoS Negl Trop Dis; 2019 Nov; 13(11):e0007800. PubMed ID: 31725816 [TBL] [Abstract][Full Text] [Related]
7. Genetically modified rabies virus ERA strain is safe and induces long-lasting protective immune response in dogs after oral vaccination. Shuai L; Feng N; Wang X; Ge J; Wen Z; Chen W; Qin L; Xia X; Bu Z Antiviral Res; 2015 Sep; 121():9-15. PubMed ID: 26093157 [TBL] [Abstract][Full Text] [Related]
8. Safety and serological response to a matrix gene-deleted rabies virus-based vaccine vector in dogs. McGettigan JP; David F; Figueiredo MD; Minke J; Mebatsion T; Schnell MJ Vaccine; 2014 Mar; 32(15):1716-9. PubMed ID: 24508037 [TBL] [Abstract][Full Text] [Related]
10. Comparison of intradermal and intramuscular delivery followed by in vivo electroporation of SIV Env DNA in macaques. Kulkarni V; Rosati M; Bear J; Pilkington GR; Jalah R; Bergamaschi C; Singh AK; Alicea C; Chowdhury B; Zhang GM; Kim EY; Wolinsky SM; Huang W; Guan Y; LaBranche C; Montefiori DC; Broderick KE; Sardesai NY; Valentin A; Felber BK; Pavlakis GN Hum Vaccin Immunother; 2013 Oct; 9(10):2081-94. PubMed ID: 23811579 [TBL] [Abstract][Full Text] [Related]
11. Recombinant simian varicella viruses induce immune responses to simian immunodeficiency virus (SIV) antigens in immunized vervet monkeys. Ou Y; Traina-Dorge V; Davis KA; Gray WL Virology; 2007 Aug; 364(2):291-300. PubMed ID: 17434552 [TBL] [Abstract][Full Text] [Related]
12. Antibody responses elicited in macaques immunized with human immunodeficiency virus type 1 (HIV-1) SF162-derived gp140 envelope immunogens: comparison with those elicited during homologous simian/human immunodeficiency virus SHIVSF162P4 and heterologous HIV-1 infection. Derby NR; Kraft Z; Kan E; Crooks ET; Barnett SW; Srivastava IK; Binley JM; Stamatatos L J Virol; 2006 Sep; 80(17):8745-62. PubMed ID: 16912322 [TBL] [Abstract][Full Text] [Related]
13. Construction and immunogenicity of a recombinant pseudotype baculovirus expressing the glycoprotein of rabies virus in mice. Huang H; Xiao S; Qin J; Jiang Y; Yang S; Li T; Gao Y; Li Z; Li T; Su X; Ruan Y; Xu F; Wang H; Chen H; Xia X Arch Virol; 2011 May; 156(5):753-8. PubMed ID: 21221673 [TBL] [Abstract][Full Text] [Related]
14. A rabies virus vectored severe fever with thrombocytopenia syndrome (SFTS) bivalent candidate vaccine confers protective immune responses in mice. Tian L; Yan L; Zheng W; Lei X; Fu Q; Xue X; Wang X; Xia X; Zheng X Vet Microbiol; 2021 Jun; 257():109076. PubMed ID: 33957572 [TBL] [Abstract][Full Text] [Related]
15. Virus-Like Vesicles Based on Semliki Forest Virus-Containing Rabies Virus Glycoprotein Make a Safe and Efficacious Rabies Vaccine Candidate in a Mouse Model. Zhang C; Tian Y; Chen C; Wang Z; Pei J; Lin C; Zhou M; Fu ZF; Zhao L J Virol; 2021 Sep; 95(20):e0079021. PubMed ID: 34346765 [TBL] [Abstract][Full Text] [Related]
16. The kinetics of specific immune responses in rhesus monkeys inoculated with live recombinant BCG expressing SIV Gag, Pol, Env, and Nef proteins. Leung NJ; Aldovini A; Young R; Jarvis MA; Smith JM; Meyer D; Anderson DE; Carlos MP; Gardner MB; Torres JV Virology; 2000 Mar; 268(1):94-103. PubMed ID: 10683331 [TBL] [Abstract][Full Text] [Related]
17. Breakthrough Virus Neutralization Resistance as a Correlate of Protection in a Nonhuman Primate Heterologous Simian Immunodeficiency Virus Vaccine Challenge Study. Lee FH; Mason R; Welles H; Learn GH; Keele BF; Roederer M; Bar KJ J Virol; 2015 Dec; 89(24):12388-400. PubMed ID: 26423953 [TBL] [Abstract][Full Text] [Related]